Over the decades, a variety of chemically synthesized drugs are being used to cure existing diseases but often these drugs could not be effectively employed for the treatment of serious and newly emerging diseases. Fortunately, in nature there occurs immense treasure of plants and microorganisms which are living jewels with respect to their richness of medically important metabolites of high value. Hence, amongst the existing microorganism(s), the marine world offers a plethora of biological entities that can contribute to alleviate numerous human ailments. Algae are one such photosynthetic microorganism found in both marine as well as fresh water which are rich source of metabolites known for their nutrient content and health benefits. Various algal species like Haematococcus, Diatoms, Griffithsia, Chlorella, Spirulina, Ulva, etc. have been identified and isolated to produce biologically active and pharmaceutically important high value compounds like astaxanthin, fucoxanthin, sulphur polysaccharides mainly galactose, rhamnose, xylose, fucose etc., which show antimicrobial, antifungal, anti-cancer, and antiviral activities. However, the production of either of these bio compounds is favored under conditions of stress. This review gives detailed information on various nutraceutical metabolites extracted from algae. Additionally focus has been made on the role of these bio compounds extracted from algae especially sulphur polysaccharides to treat several diseases with prospective treatment for SARS-CoV-2. Lastly it covers the knowledge gaps and future perspectives in this area of research.

Production of indole-3-acetic acid (IAA) is well documented in various studies for the bacteria that inhabit the rhizosphere of plants, but with roots of wet rice, the outstandings have been not yet elucidated. This study began with the isolation of bacteria type strain Azospirillum sp. and developed the investigation to a screening of their ability in IAA production. This screening conducted a selection of only bacteria that was capable of the production of IAA with its content of over 25 µg. mL-1 for sequencing. Of 10 isolates only one resulted from the type strain Azospirillum brasilense (A. brasilense) with a similarity of 100%. Various factors that influence A. brasilense in biosynthesizing IAA such as temperature, pH, nitrogen presence and concentration of tryptophan in the culture medium were examined. The results indicated that the culture conditions were suitable for IAA biosynthesis at pH 6.5, 30 °C, culture media with nitrogen, and 0.1% trytophan. The next survey on the role of the immobilization of this bacteria with microalgae in alginate was highlighted to its support in microalgal growth. With the co-immobilization of bacteria and microalgae, the density of Chlorella vulgaris was significantly increased during 15-day culture, inducing 2.2 times of cell content in culture batch microalgae immobilized A. brasilense higher than that free-bacteria.

The paper industry is one of the most important basic raw material pillar industries. With the decrease of forest wood resources, the recycling of wastepaper has drawn increasingly attention. However, the stickies generated in the process of wastepaper recycling will flocculate and deposite in the pulp, resulting in production accidents and inferior product quality. The biological enzymatic method, with the advantages of high efficiency, specificity, and pollution-free, can prevent the flocculation of the stickies by enzymatically hydrolyzing the ester bond of the stickies components. Previous studies have demonstrated that cutinase (EC 3.1.1.74) had the ability to degrade polyester components of stickies. Meanwhile, relevant studies have shown that anchor peptides possessed the ability to bind polyester. Herein, the cutinase from Humicola insolens (HiC) was fused with Escherichia coli anchor peptide OMP25, the enzymatic properties of the fusion protein HiC-OMP25 and its degradation efficiency of the stickies model substrate, poly(ethyl acrylate) (PEA) and poly(vinyl acetate) (PVAc), as well as stickies sediment were determined. All of the results demonstrated that OMP25 efficiently enhanced the degradation ability of HiC.

Recombinant Cupriavidus necator H16/pMPJAS03, expressing a P. putida KT2440 enoyl-CoA hydratase (phaJ), was able to synthesize short-chain-length/ medium-chain-length (scl-mcl) PHA copolymers with a high content of mcl subunits using its native poly(3-hydroxyalkanoate) synthase. The cells were cultivated on fructose with canola oil or canola oil/decanoic acid (DA) mixtures in fed-batch fermentations. The recombinant C. necator H16 (without any synthase modification) produced a polymer composed of 3-hydroxybutyrate (3HB) with mcl-subunits, including 3-hydroxyhexanoate (3HHx), and about 300-fold more 3-hydroxyoctanoate (3HO) than the yields reported in previous studies, as well as a significant amount of 3-hydroxydecanoate (3HD). Increasing the DA content in the feed from 0% to 15% v/v increased the molar content of the 3HD subunits from 1.2 to 2.1 mol%. The presence of larger monomers, such as 3HO and 3HD, decreased the crystallinity and melting temperature and modified the mechanical properties of the polymers. Thus, replacing either of the two gene products (phaJ or phaC1) required to produce PHA from CoA-3-hydroxy fatty acids with broader spectrum enzymes, is suitable for the production of commercially useful scl-mcl-PHA.

Actinobacteria have many properties that make them good candidates for the bioremediation of sites contaminated by several organic and inorganic pollutants. However, studies on the biodegradation of used motor oils by Actinobacteria, compared to other bacteria, remain little studied. Actinobacteria were isolated from soil contaminated with used motor oils and sewage sludge in order to select a species that can effectively degrade such pollutants. This study aims to assess their degradation capacity of the various hydrocarbon fractions contained in the oil by gas chromatography-mass spectrometry (GC-MS). Five Actinobacteria isolates were isolated by the enrichment method. The S1.1. A strain was considered the best biosurfactant producing strain. It presents the highest emulsification index compared to other isolated Actinobacteria (82.6%). Phenotypic and molecular identification by sequencing the 16 S rDNA gene makes it possible to assign this isolate to the species Streptomyces ginkgonis KM-1-2. Gravimetric analysis results of biodegraded used motor oil indicated that this strain is capable of degrading 76.4% of an initial 50 ml/l concentration of used motor oil after 4 weeks of incubation. The results of GC-MS analysis of the residual motor oil showed that strain S1.1. A degraded some long and intermediate chain alkanes completely or to shorter fractions. The Streptomyces ginkgonis strain KM-1-2 was also able to degrade certain alkylated mono-aromatic hydrocarbons linked to benzene, as well as certain alkylated and non-alkylated polycyclic aromatic hydrocarbons linked to anthracene, naphthalene, phenanthrene, fluorene, and azulene. This strain exhibited the highest emulsification index at 82.6%. This bacterium shows a significant biodegradation capacity and could, consequently, be used in the processes of bioaugmentation of sites contaminated by these oils.

In recent years, acceleration of development timelines has become a major focus within the biopharmaceutical industry to bring innovative therapies faster to patients. However, in order to address a high unmet medical need even faster further acceleration potential has to be identified to transform "speed-to-clinic" concepts into "warp-speed" development programs. Recombinant Chinese hamster ovary (CHO) cell lines are the predominant expression system for monoclonal antibodies (mAbs) and are routinely generated by random transgene integration (RTI) of the genetic information into the host cell genome. This process, however, exhibits considerable challenges such as the requirement for a time-consuming clone screening process to identify a suitable clonally derived manufacturing cell line. Hence, RTI represents an error prone and tedious method leading to long development timelines until availability of Good Manufacturing Practice (GMP)-grade drug substance (DS). Transposase-mediated semi-targeted transgene integration (STI) has been recently identified as a promising alternative to RTI as it allows for a more rapid generation of high-performing and stable production cell lines. In this report, we demonstrate how a STI technology was leveraged to develop a very robust DS manufacturing process based on a stable pool cell line at unprecedented pace. Application of the novel strategy resulted in the manufacturing of GMP-grade DS at 2,000 L scale in less than three months paving the way for a start of Phase I clinical trials only six months after transfection. Finally, using a clonally derived production cell line, which was established from the parental stable pool, we were able to successfully implement a process with an increased mAb titer of up to 5 g per liter at the envisioned commercial scale (12,000 L) within eight months.